Hemab Therapeutics Holdings COAG
NASDAQ COAG
$40.86 +1.48 (+3.76%)
At close: Nov 13, 2026 · 4:00 PM EST

Hemab Therapeutics Holdings (COAG) Other Non Operating Income (2025 - 2026)

Updated

Hemab Therapeutics Holdings (COAG) reported Other Non Operating Income of -$237,000 for Q3 2026, compared with -$127,000 a year earlier.

Analysis

Hemab Therapeutics Holdings (COAG) Other Non Operating Income (2025 - 2026) Analysis & Trends

Over the twelve months ended Sep 30, 2026, Hemab Therapeutics Holdings' Other Non Operating Income came in at -$1.48 million.

  • Five-year quarterly Other Non Operating Income spans a low of -$832,000 in Q2 2026 and a high of $3.52 million in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn
10 Hemab Therapeutics Holdings 1.91 Bn 672.70 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -237,000.00
Jun 30, 2026 -832,000.00
Mar 31, 2026 -282,000.00
Sep 30, 2025 -127,000.00
Jun 30, 2025 3.52 Mn
Mar 31, 2025 591,000.00
API Access

Hemab Therapeutics Holdings Other Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=COAG&period=max&api_key=YOUR_API_KEY